跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT02550847
NCT02550847Unknown不适用

Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年8月最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
The tumor recurrence rate after operation at 6 months
研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The aim of this study was to evaluate MR/PET with both functional and molecular imaging on the prediction of prognosis in patients with suspected pancreatic cancer.

详细描述

The results of MR/PET will be compared prospectively to dedicated MDCT or MR imaging, pathologic results, and clinical outcomes to assess the value of MR/PET in pancreatic cancers.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
20 Years 至 90 Years（Adult, Older Adult）
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosed as pancreatic cancer
  • •Between 20~90 years old
  • •Normal renal function
  • •Measurable tumor size (>1cm)

排除标准

  • •Contraindication for MRI exam
  • •Claustrophobia
  • •Renal insufficiency
  • •Other malignancy
  • •Pregnancy and lactating women

结局指标

主要结局

The tumor recurrence rate after operation at 6 months

时间窗: 6 months

次要结局

  • The overall survival after operation at 6 months(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

终止
不适用
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical CancerCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedCervical Undifferentiated CarcinomaRecurrent Cervical CarcinomaStage IB2 Cervical CancerStage II Cervical CancerStage IIA Cervical CancerStage IIB Cervical CancerStage III Cervical CancerStage IIIA Cervical CancerStage IIIB Cervical CancerStage IVA Cervical Cancer
NCT01992861University of Washington51
已完成
不适用
PET-MR for Prediction and Monitoring of Response to Neoadjuvant Chemotherapy in Breast CancerBreast Cancer
NCT01190566Seoul National University Hospital57
Unknown
不适用
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular CarcinomaHepatocellular Carcinoma
NCT02550613National Taiwan University Hospital100
尚未招募
2 期
PET/MRI in Rectal CancerRectal Cancer
NCT06057831AHS Cancer Control Alberta40
已完成
不适用
Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility StudyIBD
NCT02364973Turku University Hospital20